New Plan Focuses on Poultry Health and Egg Price Stability
The USDA has outlined a strategic blueprint to control the highly pathogenic avian influenza (HPAI), which has drastically impacted the U.S. poultry industry and egg market since its resurgence. This plan includes significant financial and strategic measures to curb the spread and effects of the disease.
Since 2022, HPAI has affected approximately 166 million birds, predominantly egg-laying hens, significantly reducing the egg supply and escalating prices. Recently, egg prices soared to a record $8.11 per dozen, reflecting the severity of the outbreak.
The USDA's response includes a $500 million allocation for enhancing biosecurity standards across poultry farms. Additionally, $400 million is earmarked for financial relief to affected farmers. Exploring vaccine and therapeutic options for laying hens forms another critical aspect of the strategy.
The blueprint proposes reducing regulatory burdens on egg producers and considering temporary egg imports to alleviate price pressures. This comprehensive approach aims not only to manage the current crisis but also to prevent future outbreaks.
The USDA maintains a dedicated avian influenza dashboard and publishes regular reports, such as the Chicken and Egg Report, to monitor the situation and aid in the recovery and stabilization of the poultry sector.